EDGAR Filing Documents for 0001437749-23-006958

Form 8-K - Current report:

SEC Accession No. 0001437749-23-006958

Filing Date

2023-03-17

Accepted

2023-03-16 21:43:19

Documents

Period of Report

2023-03-10

Items

Item 1.01: Entry into a Material Definitive Agreement
Item 3.02: Unregistered Sales of Equity Securities
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq	Description	Document	Type	Size
1	FORM 8-K	arch20230315_8k.htm iXBRL	8-K	43003
2	EXHIBIT 10.1	ex_489319.htm	EX-10.1	35495
3	EXHIBIT 10.2	ex_489320.htm	EX-10.2	22028
4	EXHIBIT 10.3	ex_489321.htm	EX-10.3	22002
5	EXHIBIT 10.4	ex_489322.htm	EX-10.4	13843
6	EXHIBIT 10.5	ex_489323.htm	EX-10.5	13767
7	EXHIBIT 10.6	ex_489324.htm	EX-10.6	16491
8	EXHIBIT 10.7	ex_489325.htm	EX-10.7	16673
	Complete submission text file	0001437749-23-006958.txt		341158

Data Files

Seq	Description	Document	Type	Size
9	XBRL TAXONOMY EXTENSION SCHEMA	arch-20230310.xsd	EX-101.SCH	3602
10	XBRL TAXONOMY EXTENSION DEFINITION LINKBASE	arch-20230310_def.xml	EX-101.DEF	10450
11	XBRL TAXONOMY EXTENSION LABEL LINKBASE	arch-20230310_lab.xml	EX-101.LAB	13929
12	XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE	arch-20230310_pre.xml	EX-101.PRE	10441
14	EXTRACTED XBRL INSTANCE DOCUMENT	arch20230315_8k_htm.xml	XML	2324

Mailing Address 235 WALNUT STREET, SUITE 6 FRAMINGHAM MA 01702

Business Address 235 WALNUT STREET, SUITE 6 FRAMINGHAM MA 01702 617-431-2313

Arch Therapeutics, Inc. (Filer) CIK: 0001537561 (see all company filings)